Literature DB >> 7503947

Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors.

M Perretti1, A Ahluwalia, R J Flower, S Manzini.   

Abstract

Pretreatment of mice with capsaicin resulted in approximately 40% inhibition of the polymorphonuclear leucocyte (PMN) influx elicited by interleukin-1 (IL-1) injected into a murine air-pouch. This inhibition was mimicked by two selective antagonists of neurokinin-1 (NK-1) tachykinin (TK) receptors, i.e. CP-96,345 and RP-67,580, but not by the inactive enantiomer RP-68,651. A selective NK-2 antagonist, SR-48,968, was inactive. The natural peptide, substance P (SP), and a selective NK-1 agonist, (Sar9)SP, induced PMN infiltration into the murine air-pouch, whereas a selective NK-2 agonist, (beta Ala8)NK-A(4-10), was ineffective. Moreover, SP-induced PMN accumulation was prevented by co-administration of RP-67,580 and CP-96,345, but not by RP-68,651. These findings suggest that the release of an endogenous TK, possibly SP, may occur following IL-1 injection in vivo, indicating a contributory role for neuropeptides in the PMN migration elicited by this cytokine. The action of selective agonists and antagonists suggests the involvement of NK-1 receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7503947      PMCID: PMC1422103     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.

Authors:  M P Bevilacqua; S Stengelin; M A Gimbrone; B Seed
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

2.  Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent.

Authors:  H Yano; B K Wershil; N Arizono; S J Galli
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 3.  Neuropeptides and inflammation: the role of substance P.

Authors:  D G Payan
Journal:  Annu Rev Med       Date:  1989       Impact factor: 13.739

4.  Evidence that neutrophil accumulation induced by interleukin-1 requires both local protein biosynthesis and neutrophil CD18 antigen expression in vivo.

Authors:  M Rampart; T J Williams
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

5.  Substance-P-like levels in inflammatory exudates.

Authors:  M Tissot; P Pradelles; J P Giroud
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

6.  Effect of neuropeptides on production of inflammatory cytokines by human monocytes.

Authors:  M Lotz; J H Vaughan; D A Carson
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

7.  Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1.

Authors:  M Perretti; R J Flower
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

8.  Tachykinins: effects on motility and metabolism of rat polymorphonuclear leucocytes.

Authors:  M Roch-Arveiller; D Regoli; B Chanaud; M Lenoir; O Muntaner; S Stralzko; J P Giroud
Journal:  Pharmacology       Date:  1986       Impact factor: 2.547

9.  Intraneuronal substance P contributes to the severity of experimental arthritis.

Authors:  J D Levine; R Clark; M Devor; C Helms; M A Moskowitz; A I Basbaum
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

10.  Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury.

Authors:  A Saria
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

View more
  15 in total

1.  Interactive contribution of NK(1) and kinin receptors to the acute inflammatory oedema observed in response to noxious heat stimulation: studies in NK(1) receptor knockout mice.

Authors:  A Rawlingson; N P Gerard; S D Brain
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease.

Authors:  D Moriarty; J Goldhill; N Selve; D P O'Donoghue; A W Baird
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

3.  Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors.

Authors:  A J Davis; M N Perkins
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 4.  Neuro-Immune Networks in Gastrointestinal Disorders.

Authors:  Mohammad Khalil; Zehua Zhang; Matthias A Engel
Journal:  Visc Med       Date:  2019-02-04

5.  Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells.

Authors:  S H P Oliveira; C Canetti; R A Ribeiro; F Q Cunha
Journal:  Inflammation       Date:  2008-02       Impact factor: 4.092

6.  Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse.

Authors:  M Perretti; C Szabó; C Thiemermann
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

7.  Reduction of inflammation and pyrexia in the rat by oral administration of SDZ 224-015, an inhibitor of the interleukin-1 beta converting enzyme.

Authors:  P R Elford; R Heng; L Révész; A R MacKenzie
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

8.  Demonstration of a 'septide-sensitive' inflammatory response in rat skin.

Authors:  A Ahluwalia; S Giuliani; C A Maggi
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

9.  Human neutrophils as a source of nociceptin: a novel link between pain and inflammation.

Authors:  Marie-Elaine Fiset; Caroline Gilbert; Patrice E Poubelle; Marc Pouliot
Journal:  Biochemistry       Date:  2003-09-09       Impact factor: 3.162

10.  Delay of cutaneous wound closure by morphine via local blockade of peripheral tachykinin release.

Authors:  Jerri M Rook; Kenneth E McCarson
Journal:  Biochem Pharmacol       Date:  2007-06-14       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.